Events The 3rd International Electronic Conference on Biomedicines

Event submissions

Published

This submission belongs to the session S6. Diabetes, Obesity and Metabolic Diseases of the event The 3rd International Electronic Conference on Biomedicines

Published date

09 May, 2025

Academic Editor

Serafino Fazio

Citation

Nesteve John Agosto, In silico molecular docking and ADMET prediction of <em>Ginkgo biloba</em> biflavonoids as dual inhibitors of human HMG-CoA reductase and alpha-amylase, in Proceedings of The 3rd International Electronic Conference on Biomedicines, 12 May–15 May 2025, MDPI: Basel, Switzerland

FaceBook

Twitter

In silico molecular docking and ADMET prediction of Ginkgo biloba biflavonoids as dual inhibitors of human HMG-CoA reductase and alpha-amylase

Nesteve John Agosto ^1,2

1. Department of Chemistry, University of Science and Technology of Southern Philippines, Cagayan de Oro City, 9000, Philippines

2. Center for Natural Products Research, University of Science and Technology of Southern Philippines, Cagayan de Oro City, 9000, Philippines

Abstract

Keywords

bilobetin

hypercholesterolemia

diabetes

binding affinity

pharmacokinetic properties

computer-aided drug discovery